Skip to content

Peripheral Magnetic Stimulation to Treat Patient With Post-stroke Shoulder-hand Syndrome

Therapeutic Effect of Peripheral Magnetic Stimulation Generated by the Super-inductive System to Treat Patient With Post-stroke Shoulder-hand Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05112094
Enrollment
40
Registered
2021-11-08
Start date
2021-08-01
Completion date
2022-06-30
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflex Sympathetic Dystrophy of Upper Limb, Stroke

Keywords

shoulder pain, magnetic stimulation, electric stimulation, reflex sympathetic dystrophy

Brief summary

Shoulder-hand syndrome is a common complication following stroke, constituting of excessive pain, swelling, heat, limited range of motion, and trophic change of the affected limbs. It not only has an extensive negative impact on both physical and psychological aspects of a stroke patient's well-being, but also impose burden on the health care system and the patient's family. Despite its relatively high incidence, there is neither well-established treatment protocol, nor high quality evidence for a single effective treatment. The objective of the present study is to investigate the efficacy, including pain, spasticity, and subluxation reduction, muscle strengthening, and shoulder range of motion improvement, of high-intensity peripheral magnetic stimulation generated by the super-inductive system to treat patients with post-stroke shoulder-hand syndrome.

Detailed description

The present study aims to investigate the therapeutic effects achieved by the peripheral magnetic stimulation for treating post-stroke shoulder-hand syndrome. The investigators plan to use high-intensity peripheral magnetic stimulation generated by the super-inductive system for treatment of post-stroke shoulder-hand syndrome. In terms of study design, the treatment group will receive 10 sessions of high-intensity peripheral magnetic stimulation 5 days a week for 2 weeks, with physical and occupational therapy kept as usual; while the control group will only receive conventional physical and occupational therapy. Comprehensive assessment, including history taking and physical examination testing for muscle strength, spasticity, shoulder range of motion, before and after the intervention will be conducted for evaluation.

Interventions

peripheral magnetic stimulation at ipsilateral shoulder ((50-80% output, 20-40Hz, pulse duration 3-5 seconds, for 15 minutes) ) + regular physical therapy(shoulder range of motion exercise and stretching 30-40 minutes per day)

OTHERphysical therapy

regular physical therapy(shoulder range of motion exercise and stretching 30-40 minutes per day)

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* \>=20 years old * Stroke in recent 6 months * Clear consciousness * Clinical diagnosis of post-stroke shoulder-hand syndrome

Exclusion criteria

* Acute bursitis, tendonitis or tendon tear * Fracture, dislocation or joint infection within 3 months * Malignancy at treatment site * Seizure * Prosthesis or implant at treatment site * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
pain0,7, 14,28 dayschange of 10-point Visual Analog Scale (0-10, higher scores mean a worse outcome)

Secondary

MeasureTime frameDescription
strength of upper limb0,7, 14,28 dayschange of score of Manual muscle testing (0-5, higher scores mean a better outcome)
spasticity of upper limb0,7, 14,28 dayschange of Modified Ashworth Scale (0-4, higher scores mean a worse outcome)
range of motion of shoulder0,7, 14,28 daysChange in range of motion in degree in flexion, extension, abduction, external and internal rotation (0-180 degrees,higher scores mean a better outcome)

Countries

Taiwan

Contacts

Primary ContactMing Yen Hsiao
myferrant@gmail.com0972652857

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026